Recruiting adults who are 18 to 70 years of age, inclusive with a clinical diagnosis of plaque psoriasis for 6 months or more, to participate in a clinical research trial. Must have stable moderate to severe chronic plaque psoriasis (assessed at the Screening and Baseline visits). Other eligibility criteria apply.
Participants will receive investigational oral treatment (active study drug) or placebo, in tablet form. Study treatment and study-related assessments will be provided at no cost. Reimbursement for study-related expenses may be provided.
Study participation will last about 20 weeks and involve about 8 visits to the study centre.
Naples - Kirsch Dermatology
Edmonton - Alberta DermaSurgery Centre
Mason - Dermatologists of Southwest Ohio
Waterloo - Alliance Clinical Trials
Markham - Lynderm Research Inc.
Winnipeg - Wiseman Dermatology Research Inc.
Surrey - Enverus Medical Research
Similar Trials
No Similar Trials FoundThe following information is from ClinicalTrials.gov
Last Update Posted: May 02, 2023
Dice Therapeutics
Condition or Disease:
Plaque Psoriasis
Ages Eligible for Study:
18 to 70
Terms and Conditions – ClinicalTrials.gov
Purpose of ClinicalTrials.gov Database. The U.S. National Institutes of Health, Department of Health and Human Services, through its National Library of Medicine, has developed ClinicalTrials.gov to provide patients, family members, and members of the public current information about clinical research studies.
register now